Follow the Ardent Health, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €1.6bn. The latest transaction was disclosed on 27 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Bonick Martin. Every trade is free.
39
Insider Decl.
n/a
Thresholds
€160,490
2 ops.
Buy Volume
n/a
n/a
Sell Volume
52Σ signal
Buys €160,490n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,412 of 29,024 companies
63.7
score / 100
Value
83
Quality
45
FCF yld17%
Earn yld8.8%
EV/EBITDA7.8x
ROE10.0%
Gross mgn41%
Net mgn2.1%
Debt/EBITDA4.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,510 shares@ US$8.5611.2% of flowCommon StockSEC:0001628280-26-023205:0
25 of 39 declarations
About Ardent Health, Inc.
Ardent Health, Inc. is a healthcare company based in the United States, specializing in the management of hospitals and health services. It primarily operates on the XNAS stock market.